SwedenBIO’s annual report 2021

SwedenBIO's annual report 2021 is now available to read.

In the annual report, we provide information on how we worked during the previous year to meet our objectives. We talk about how we have worked to help our members strengthen their business networks, how we have disseminated facts and knowledge, and how we have worked to give the industry a strong voice.

The importance of the life science industry for society’s crisis preparedness came into focus in connection with the pandemic outbreak and has in 2021 continued to generate a need for rapid action by SwedenBIO’s members and secretariat.

Member base 2021

In 2021, 41 companies joined as new members and at the end of the year SwedenBIO gathered 313 member companies. Of these, 75% were life science companies and the rest were service companies and partner organizations.

SwedenBIO’s member companies in 2021 consisted of life science companies, service companies, and partner organizations.

A particularly strong growth in membership has taken place in the healthtech/medtech/diagnostics segment, and SwedenBIO now covers a wide range of Swedish life science, with a focus on those companies that have operations in Sweden in the form of research, development and/or production. We have also increased the number of members among international companies with sales offices in Sweden. These two trends make us stronger as an organization and as an industry – the whole has become our niche.

International connectivity

Our industry is international in every sense, from research to market. In all areas of activity, SwedenBIO therefore strives for a strong international connection to life science nodes around the world.

Among other things, we work to position the Nordic region as an attractive life science region for investment, establishment and collaboration. This is, of course, a long-term effort, but we can already see clear progress with a record participation of international investors at this year’s event. Nordic Life Science Days, an increased footprint in the international media and a breakthrough in how the Nordic governments are now working to pool their efforts for the Nordic life science industry.

Strengthened secretariat and dedicated working groups

During the year, a larger communication team was established within SwedenBIO, partly through the recruitment of a communication manager and a digital communicator, and partly by more clearly gathering consultants and other resources that are used for various initiatives.

We can work broadly thanks to our working groups, task forces and other dedicated
member representatives
. These help us respond to referrals, plan and execute
campaigns, courting decision-makers and much more.

In 2021, our member representatives have made extensive contributions to the working groups run by the Life Science Office in the areas of vaccine production/societal preparedness, ATMP (Advanced Therapy Medicinal Products) and health data. Reports and proposals have been delivered to the Government Offices.

We are proud and grateful that, together with our 313 member companies, we have contributed to a strong Swedish life science industry that delivers ever-increasing value to society as a whole – patients and their relatives, the healthcare system and a wide range of financiers ranging from individual small savers to large pension funds.

Read the full report here.